The British Embassy, in collaboration with MassBio, BIO, and the British Consulate General, will host this half-day event to discuss the Trans Atlantic Trade and Investment Partnership (TTIP) and the biopharmaceutical industry.  The event will disucss the regulatory hurdles that currently exist in the biopharmaceutical sector, and what changes to the regulatory regimes TTIP might deliver.